- Eqova Life Sciences subsidiary serves underserved market in booming CBD sector
- Clinical-grade, full-spectrum hemp oil products specifically produced for licensed medical use
- CBD market expected to grow 700% to $2.1 billion by 2020
Grey Cloak Tech Inc. (OTCQB: GRCK), a Las Vegas, Nevada-based company, targets the rapidly growing cannabinoid (CBD) market through its wholly owned subsidiary Eqova Life Sciences, which focuses on providing a full spectrum line of clinical-grade hemp oil (CBD) products to the medical practitioner market. Eqova Life Sciences develops its own high quality, branded product line of hemp oil health products, with the offer of producing private labels to qualified partners.
Eqova Life Sciences recently exhibited the company’s CBD products at the Integrative Medicine Summit in Denver, Colorado, which was attended by over 200 medical professionals. As part of the exhibition, Eqova Life Sciences also debuted its new CannaBio Salve, an innovative topical salve infused with several aromatic natural oils. The company’s formulations combine the scientifically-validated, powerful benefits of cannabinoids in standardized products which are then distributed to patients under the care of qualified health practitioners. All Eqova products are carefully researched and go through rigorous third-party testing before and after marketing, providing the security of a clinical-grade product made in cGMP Compliant Labs located in the United States.
Read the full article